Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

September 6, 2018

Primary Completion Date

October 1, 2022

Study Completion Date

August 1, 2024

Conditions
HIV InfectionsPulmonary Disease
Interventions
DIAGNOSTIC_TEST

PFT's (pulmonary function testing)

The routine lung function endpoints of FVC(forced vital capacity), FEV1, FEV1/FVC, and FEF25-75% will be measured with the flow-volume loop recorder before and after bronchodilator administration. The system is calibrated for body temperature and pressure of saturated gas and volumes, per American Thoracic Society (ATS) standards . DLco will be measured using the automated single-breath procedure of the integrated testing system, which conforms with ATS standards.

Trial Locations (1)

15213

University of Pittsburgh department of medicine division of Pulmonary, Allergy and Critical Care medicine, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT03572335 - Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV) | Biotech Hunter | Biotech Hunter